Top searches

PL

Resources

B2RLaw advises Proteon Pharmaceuticals on a strategic partnership with Skretting

01/02/2021

B2RLaw has advised Proteon Pharmaceuticals on a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry.

The companies will collaborate on developing products using bacteriophage technology to support aquaculture farmers as part of a holistic health strategy. The companies will work in a parallel R&D pipeline on the project.

The Partnership allows Proteon to grow its product portfolio in aquaculture and expand its presence worldwide. Both Proteon Pharmaceuticals and Skretting predict that the technology will become a valuable component of integrated management strategies on-farm with both feed and water applications under investigation.

Proteon Pharmaceuticals is a Polish originating biotech company with a vision to develop natural feed additives that help remove antibiotics from the food chain and improve animal and human health. The Company uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

Norwegian company, Skretting is the world’s largest producer of feeds for farmed fish. The Company has operations on five continents and produces 2.5 million tonnes of feed annually, for more than sixty species of fish. Skretting has 3,500 employees worldwide. Skretting has an R&D unit known as Skretting Aquaculture Research Centre (ARC) with the main objective to provide research and technical support regarding fish and shrimp feed. It has 140 employees representing 25 nationalities.

B2RLaw’s team advising Proteon Pharmaceuticals was led by Partner George Havaris and included Counsels Paulina Wyrostek and Malwina Niczke – Chmura.

George Havaris advises, “Proteon Pharmaceuticals is a Polish company that is well on the path to being a global leader in its field of operation. Animal health is a little-known industry in the wider public eye. However, animal health is fundamental to the health and well-being of humans. We congratulate Proteon and Skretting on this exciting Partnership and we look forward to continuing our support to Proteon on its growth path”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

03/10/2022

Is Poland Up to the Task on Ukraine? Three Arguments For and Against

On whether Poland will be able to live up to its ambition of becoming a defense sector and Ukraine reconstruction […]

MORE
30/09/2022

European response to cyberwar. NIS-2 – an opportunity for increased levels of cyber security?

More than two months ago, on 13 July, after a political agreement was reached between the European Parliament and EU […]

MORE
26/09/2022

B2RLaw joins the EU VAT Expert Group

On September 12, the European Commission: Directorate-General for Taxation and Customs Union published a list of members of the VAT […]

MORE
22/09/2022

B2RLaw as an official legal advisor and partner of the Polish Paddle Tennis Federation

According to the wording of the agreement signed on September, 2022, the B2RLaw law firm has become the official and […]

MORE
09/09/2022

B2RLaw on INCBA Europe Cannabis Business Expo: 10-11 September 2022 in Zurich

Join us on the very first conference of lawyers active in the cannabis industry in Europe ever: INCBA Europe Cannabis Business […]

MORE
11/07/2022

B2RLaw advises early stage technology company The Village Network on financing received by a group of investors including Credo Ventures, 500 Startup and Tilia Impact Ventures

B2RLaw has once again advised The Village Network, the Polish company behind Wioski.co, which is run by three female entrepreneurs, […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close